Navigation Links
Asthma Breath Test in Diagnosis of Chronic Cough

According to a team from the Mayo Clinic, whether inhaled corticosteroids can treat a patient's chronic cough can be found out with the help of a simple, fast and economical test; asthma breath test.//

Cough lasting for a few weeks or longer is termed chronic cough. Postnasal drip syndrome, asthma and gastroesophageal reflux are the major causes of this condition. Chronic cough may be sometimes caused by non-asthmatic eosinophilic bronchitis.

The exhaled nitric oxide test; a test commonly used for asthmatics, is a great deal simpler for patients and predicts response to corticosteroid treatment better than the other commonly used test; the methacholine challenge. This was the conclusion arrived at by the study conducted on 114 patients to assess chronic cough.

"We're thinking this could be a significant development in the field of chronic cough," study lead investigator and Mayo Clinic pulmonologist Dr. Peter Hahn said in a prepared statement.

"It could drastically change what we do for patients with chronic cough and also the guidelines for diagnosis and treatment of chronic cough. This very accurate -- but rather underused -- test could be used up front for all patients complaining of chronic cough, saving significant time and expense in other testing," he said. "It helps us get to the treatment and bring relief to the patient in the least invasive, fastest way possible."

Inflammation in the bronchial tubes of the lungs is measured by the exhaled nitric oxide test. In this test, the patient is made to breathe into the analyzer four or five times over 10 minutes. Asthma or probably non-asthmatic eosinophilic bronchitis is indicated by the abnormal scores.

In these conditions, inflammation irritates the airway and triggers coughing in the patients. Inflammation can be reduced by corticosteroids and hence, cure this type of chronic cough.

"Patients with a positive, or abnormal, exhaled nitric oxide test had a strong likelihood of response to inhaled corticosteroids, whereas a negative, or normal, exhaled nitric oxide test virtually excluded response to the medication," Hahn said. Use of the test "may potentially have a significant impact on how patients with chronic cough are evaluated and treated," he said.

The findings were presented on Sept. 6 at the European Respiratory Society Meeting in Munich, Germany.
GYT
'"/>




Related medicine news :

1. New Drug for Bronchial Asthma
2. Asthma may actually be prevented by Dust and Dirt
3. Inhaled Steroids Safe & Effective for Children with Asthma
4. What happens when Asthmatics consume Aspirin?
5. Asthma! A new warning for heart disease
6. Asthma linked to obesity
7. Higher Risk of Asthma in children with autoimmune disease
8. Asthmatics at increased risk of lung cancer
9. Cleanliness might lead to Asthma
10. Asthma is not just a childhood condition
11. Asthma not just a childhood condition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
(Date:12/6/2016)... ... 2016 , ... The International Vaccine Institute (IVI) and GeneOne ... Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine development ... in the event of a future outbreak. , IVI and GeneOne held a ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... , Dec. 7, 2016   TraceLink Inc ... for connecting the Life Sciences supply chain and ... today announced that Tjoapack has selected TraceLink,s serialization ... customers comply with the rapidly approaching serialization deadlines ... (DSCSA) in 2017 and the EU Falsified Medicines ...
(Date:12/7/2016)... ZIONA SCIENCE PARK , ... biotechnology company Kadimastem (TASE: KDST) announced today the signing of a ... collaboration between the companies. The synergy between the companies will assist ... collaboration as a worldwide leader in innovative treatment for severe diseases ... ...
Breaking Medicine Technology: